The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases
Special Notice from Department of Health and Human Services.
Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.
Closing in 950 days
Notice details
- Sub-tier agency
- NATIONAL INSTITUTES OF HEALTH
- Notice type
- Special Notice
- Solicitation number
- RFA-DK-23-017_RFA-DK-23-018
- Product/service code
- Q999
- Place of performance
- Bethesda, Maryland
- Posted
- Oct 1, 2024
- Response deadline
- May 31, 2029
- Source
- SAM.gov
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) of the Department of Health and Human Services (DHHS) seeks industry collaborators to provide novel therapeutic agents, diagnostic markers, biomarkers and devices for use in NIH-sponsored multi-center clinical trials and ancillary studies in patients with childhood cholestatic liver diseases, including biliary atresia, alpha-one antitrypsin deficiency, cystic fibrosis liver disease, Alagille syndrome, progressive familial intrahepatic cholestasis (PFIC), bile acid synthesis defects, mitochondrial respiratory chain and fatty acid oxidation defects, primary sclerosing cholangitis, and idiopathic neonatal hepatitis; and the liver disease related complications emanating from these diseases. BACKGROUND: The Childhood Liver Disease Research and Education Network (ChiLDReN) is a multi-center consortium of 10 clinical sites in the United States plus a scientific data coordinating center funded by NIDDK to study rare childhood liver diseases that result in cholestasis, including primary sclerosing cholangitis, biliary atresia, alpha-one antitrypsin deficiency, cystic fibrosis liver disease, Alagille syndrome, progressive familial intrahepatic
Summarized from the official notice. The description is shortened; read the full text on the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Prior awards (USAspending)
Department of Health and Human Services obligated $305,402,258 under NAICS 541715 on awards whose period of performance started in the last 12 months.
Source: USAspending.gov, U.S. Department of Treasury, Bureau of the Fiscal Service, https://www.usaspending.gov. Accessed Oct 24, 2026. Award totals are computed by DSE from USAspending.gov award data.
Similar open notices
- A--Strong Heart Study (SHS) - Legacy Cohort FCClosing in 6 days
- A--Strong Heart Study (SHS) Renewal - Coordinating Center (CC)Closing in 6 days
- Strong Heart Study (SHS) – New Cohort of Young Native American (NA) AdultsClosing in 6 days
- A--Risk Underlying Rural Areas Longitudinal (RURAL) HClosing in 12 days
- Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions OpeningClosing in 17 days
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is May 31, 2029. That is 950 days after the data date.
What NAICS code applies?
NAICS 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Which agency issued this notice?
Department of Health and Human Services.
Where is the official notice?
The link under Official notice opens the source listing.